A recent study found AIM2 inhibits BRAF mutated CRC growth via caspase-1 in vitro and in vivo, confirming AIM2 overexpression significantly inhibits BRAF-mutated CRC tumor growth and metastasis. Here, AIM2 is linked to colorectal carcinoma.